Overview

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
An open-label, multicentre study to evaluate the efficacy and safety of one course of weekly intramuscular administration of Amevive in Taiwan patients with chronic plaque psoriasis
Phase:
N/A
Details
Lead Sponsor:
Uni-Pharma
Collaborator:
Biogen
Treatments:
Alefacept